LUCY Graph | INNOVATIVE EYEWEAR, INC.

LUCY Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

2026-06-30: Revenue $1.01M; Cost of revenue $768.00K; Research and development $142.09K; Operating expenses $1.95M.
2026-03-31: Revenue $773.56K; Cost of revenue $598.12K; Research and development $138.11K; Operating expenses $2.55M.
2025-12-31: Revenue $959.81K*; Cost of revenue $845.06K*; Research and development $116.60K*; Operating expenses $2.61M*.
2025-09-30: Revenue $668.13K; Cost of revenue $423.29K; Research and development $129.98K; Operating expenses $2.17M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period end	Revenue	Cost of revenue	Research and development	Operating expenses	Income tax	Net income
2026-06-30	$1.01M	$768.00K	$142.09K	$1.95M	$0.00	-$1.67M
2026-03-31	$773.56K	$598.12K	$138.11K	$2.55M	$0.00	-$2.31M
2025-12-31	$959.81K*	$845.06K*	$116.60K*	$2.61M*	(m)	-$1.87M*
2025-09-30	$668.13K	$423.29K	$129.98K	$2.17M	$0.00	-$1.84M
2025-06-30	$579.23K	$591.89K	$268.22K	$2.16M	$0.00	-$2.11M
2025-03-31	$454.50K	$233.97K	$210.58K	$2.12M	$0.00	-$1.78M
2024-09-30	$253.60K	$194.25K	$131.37K	$1.82M	$0.00	-$1.72M
2024-06-30	$308.68K	$253.51K	$256.80K	$2.03M	$0.00	-$1.95M
2024-03-31	$383.47K	$376.52K	$216.30K	$2.02M	$0.00	-$1.97M
2023-09-30	$221.88K	$141.53K	$192.70K	$1.68M	$0.00	-$1.55M
2023-06-30	$169.93K	$199.75K	$197.48K	$1.30M	$0.00	-$1.29M
2023-03-31	$144.92K	$134.63K	$151.17K	$1.44M	$0.00	-$1.43M
2022-09-30	$151.96K	$129.09K	$304.69K	$1.39M	$0.00	-$1.40M
2022-06-30	$204.74K	$161.49K	$52.56K	$1.19M	$0.00	-$1.19M
2022-03-31	$236.02K	$161.63K	$35.81K	$1.26M	$0.00	-$1.21M
2021-09-30	$171.03K	$130.22K	$9.22K	$1.13M	(m)	-$1.10M
2021-06-30	$127.03K	$94.37K	$19.13K	$550.46K	(m)	-$536.60K
2021-03-31	(m)	(m)	(m)	(m)	(m)	-$221.71K

Revenue and expense 6 month

Period end	Revenue	Cost of revenue	Research and development	Operating expenses	Income tax	Net income
2026-06-30	$1.78M	$1.37M	$280.20K	$4.49M	$0.00	-$3.98M
2025-06-30	$1.03M	$825.86K	$478.80K	$4.28M	$0.00	-$3.88M
2024-06-30	$692.15K	$630.03K	$473.10K	$4.05M	$0.00	-$3.92M
2023-06-30	$314.85K	$334.38K	$348.65K	$2.74M	$0.00	-$2.72M
2022-06-30	$440.76K	$323.13K	$88.37K	$2.45M	$0.00	-$2.40M
2021-06-30	$244.15K	$202.16K	$26.90K	$776.16K	(m)	-$758.31K

Revenue and expense 9 month

Period end	Revenue	Cost of revenue	Research and development	Operating expenses	Income tax	Net income
2025-09-30	$1.70M	$1.25M	$608.78K	$6.45M	$0.00	-$5.72M
2024-09-30	$945.75K	$824.28K	$604.47K	$5.87M	$0.00	-$5.64M
2023-09-30	$536.73K	$475.91K	$541.35K	$4.42M	$0.00	-$4.27M
2022-09-30	$592.72K	$452.22K	$393.06K	$3.84M	$0.00	(m)
2021-09-30	$415.19K	$332.38K	$36.12K	$1.91M	(m)	(m)

Revenue and expense 12 month

Period end	Revenue	Cost of revenue	Research and development	Operating expenses	Net income
2025-12-31	$2.66M	$2.09M	$725.39K	$9.06M	-$7.59M
2024-12-31	$1.64M	$1.42M	$819.39K	$8.14M	-$7.77M
2023-12-31	$1.15M	$1.27M	$662.18K	$6.74M	-$6.66M
2022-12-31	$659.79K	$716.08K	$524.69K	$5.52M	-$5.68M
2021-12-31	$690.67K	$542.42K	$86.26K	$3.35M	-$3.24M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
RxSight, Inc. (RXST)	United States	$0.197B
STAAR SURGICAL CO (STAA)	United States	$0.957B	362.70
National Vision Holdings, Inc. (EYE)	United States	$1.297B
Warby Parker Inc. (WRBY)	United States	$2.970B
Bausch & Lomb Corp (BLCO)	Canada	$6.008B	-34.58
COOPER COMPANIES, INC. (COO)	United States	$10.533B	24.09